Cambridge Cognition: Wearable Cognitive Testing
Executive Summary
Pharma companies are increasingly interested in the potential for drugs to affect cognitive processes – as are regulators and patients. Cognitive impairment techniques specialist Cambridge Cognition is going a step further with work on a wearable monitoring device for assessing cognitive function and tracking symptoms of neurological and neuropsychiatric conditions.